Shanghai Hengrui Pharmaceutical Co., Ltd.

This early-stage study tests a new drug called SHR-3836 in 99 adults with multiple myeloma that has come back or not responded to other treatments. The main goal is to find a safe dose and check for side effects. Researchers will also watch for signs that the drug is shrinking th…